Literature DB >> 28642292

Frequency and magnitude of intermittent hypoxia modulate endothelial wound healing in a cell culture model of sleep apnea.

Noelia Campillo1,2, Bryan Falcones1,2, Josep M Montserrat2,3, David Gozal4, Ana Obeso2,5, Teresa Gallego-Martin2,5, Daniel Navajas1,2,6, Isaac Almendros1,2,7, Ramon Farré8,2,7.   

Abstract

Intermittent hypoxia (IH) has been implicated in the cardiovascular consequences of obstructive sleep apnea (OSA). However, the lack of suitable experimental systems has precluded assessment as to whether IH is detrimental, protective, or both for the endothelium. The aim of the work was to determine the effects of frequency and amplitude of IH oxygenation swings on aortic endothelial wound healing. Monolayers of human primary endothelial cells were wounded and subjected to constant oxygenation (1%, 4%, 13%, or 20% O2) or IH at different frequencies (0.6, 6, or 60 cycles/h) and magnitude ranges (13-4% O2 or 20-1% O2), using a novel well-controlled system, with wound healing being measured after 24 h. Cell monolayer repair was similar at 20% O2 and 13% O2, but was considerably increased (approximately twofold) in constant hypoxia at 4% O2 The magnitude and frequency of IH considerably modulated wound healing. Cycles ranging 13-4% O2 at the lowest frequency (0.6 cycles/h) accelerated endothelial wound healing by 102%. However, for IH exposures consisting of 20% to 1% O2 oscillations, wound closure was reduced compared with oscillation in the 13-4% range (by 74% and 44% at 6 cycles/h and 0.6 cycles/h, respectively). High-frequency IH patterns simulating severe OSA (60 cycles/h) did not significantly modify endothelial wound closure, regardless of the oxygenation cycle amplitude. In conclusion, the frequency and magnitude of hypoxia cycling in IH markedly alter wound healing responses and emerge as key factors determining how cells will respond in OSA.NEW & NOTEWORTHY Intermittent hypoxia (IH) induces cardiovascular consequences in obstructive sleep apnea (OSA) patients. However, the vast array of frequencies and severities of IH previously employed in OSA-related experimental studies has led to controversial results on the effects of IH. By employing an optimized IH experimental system here, we provide evidence that the frequency and magnitude of IH markedly alter human aortic endothelial wound healing, emerging as key factors determining how cells respond in OSA.
Copyright © 2017 the American Physiological Society.

Entities:  

Keywords:  endothelium; hypoxia/reoxygenation; repair; sleep apnea

Mesh:

Substances:

Year:  2017        PMID: 28642292     DOI: 10.1152/japplphysiol.00077.2017

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  5 in total

1.  Obstructive sleep apnea-Hypertension link: almost there?

Authors:  Flavio Danni Fuchs; Sandra C Fuchs; Denis Martinez
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

2.  Intermittent Hypoxia Activates Duration-Dependent Protective and Injurious Mechanisms in Mouse Lung Endothelial Cells.

Authors:  Peter Wohlrab; Lourdes Soto-Gonzales; Thomas Benesch; Max Paul Winter; Irene Marthe Lang; Klaus Markstaller; Verena Tretter; Klaus Ulrich Klein
Journal:  Front Physiol       Date:  2018-12-06       Impact factor: 4.566

3.  A model of guided cell self-organization for rapid and spontaneous formation of functional vessels.

Authors:  L Andrique; G Recher; K Alessandri; N Pujol; M Feyeux; P Bon; L Cognet; P Nassoy; A Bikfalvi
Journal:  Sci Adv       Date:  2019-06-12       Impact factor: 14.136

4.  Severe Intermittent Hypoxia Modulates the Macrophage Phenotype and Impairs Wound Healing Through Downregulation of HIF-2α.

Authors:  Lihong Chen; Yunyi Gao; Yan Li; Chun Wang; Dawei Chen; Yun Gao; Xingwu Ran
Journal:  Nat Sci Sleep       Date:  2022-08-31

5.  Intermittent Hypoxia Induced Formation of "Endothelial Cell-Colony Forming Units (EC-CFUs)" Is Affected by ROS and Oxidative Stress.

Authors:  Katia Avezov; Dror Aizenbud; Lena Lavie
Journal:  Front Neurol       Date:  2018-06-14       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.